Industries de la santé

NEW YORK (GBI Research), 22 March 2016 - The Asia-Pacific (APAC) Alzheimer’s disease market will grow from $3 billion in 2014 to $5.1 billion in 2021, representing a robust Compound Annual Growth Rate of 7.9%, according to business intelligence provider GBI Research.



The company’s latest report* states that the main driver of this impressive growth, which will occur across the...

Philippe Maitre, spécialiste de l'industrie pharmaceutique et des biotechnologies, prendra la direction de cette filiale US



Paris (France), Copenhague (Danemark), 21 mars 2016 - Onxeo S.A. (Euronext Paris, Nasdaq Copenhague : ONXEO), société innovante spécialisée dans le développement de médicaments orphelins en oncologie, annonce aujourd'hui le la création d'une filiale aux...

Des progrès essentiels dans les deux programmes phares (VIH - HBV)



Trésorerie solide qui sécurise l'atteinte des prochaines étapes-clés






Paris, le 15 Mars 2016 - ABIVAX (Euronext Paris : FR0012333284 - ABVX), société de biotechnologie leader dans le développement clinique et la commercialisation de médicaments antiviraux et de vaccins thérapeutiques pour des maladies...

NEW YORK, NY - 03/14/16 - Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium" or the "Company"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers provided investors with an update on its business progress following the filing of its 2015 10-K.



Recent Highlights

· Received clearance from the FDA for...

LONDON, UK (GlobalData), 15 March 2016 - The termination of Celldex’s Phase III trial assessing its peptide-based vaccine therapy, Rintega, in newly-diagnosed glioblastoma patients, represents a blow to the treatment space as hopes for improved therapies turn instead to Opdivo and drugs combining peptide vaccines with immuno-oncology products, according to analysts with research and...

LONDON, UK (GlobalData), 10 March 2016 - A new tobacco-based seasonal influenza vaccine being developed by Mitsubishi Tanabe Pharma and currently in Phase III studies could potentially rival traditional chicken egg-based vaccines, as it aims to launch in the US for the 2018-19 flu season, according to an analyst with research and consulting firm GlobalData.



The technology involved in...

La nouvelle technologie de détecteur et les algorithmes logiciels avancés de METTLER TOLEDO offrent de meilleurs niveaux de détection et la possibilité d'inspecter les produits à des cadences plus élevées.


Dans un monde où les technologies, les marchés et les préférences des clients évoluent rapidement, l'innovation est essentielle à la survie à long terme de n'importe...

LONDON, UK (GlobalData), 9 March 2016 - The UK Department of Health’s rejection of an 800,000-signature public petition to expand the routine administration of the only approved vaccine to offer protection against invasive meningococcal disease (IMD) caused by serogroup B (MenB), may lead to parents and physicians to consider purchasing the vaccine themselves, according to an analyst...

5 and 6 April 2016, Cologne - (PresseBox) 250 participants and 30 exhibitors from all over the world are expected to attend the established meeting point of the bio-based industry, the “9th International Conference on Bio-Based Materials”, Cologne (DE): www.bio-based.eu/conference



Market leaders will showcase the latest developments and trends in bio-based building blocks and...

Vitrines Sociétés

Voir toutes les vitrines